Wave Life Sciences: 'Strong Buy' On DMD NDA Filing WVE-N531 And Released AATD Data

2026-05-20 13:21:11 ET

The last time I spoke about Wave Life Sciences ( WVE ), it was in a Seeking Alpha article entitled " Wave Life Sciences: Potential For Accelerated Approval Pathway with WVE-N531 ." With respect to this article, I mentioned the company's advancement of WVE-N531 for potential Accelerated Approval for the treatment of patients with Duchenne Muscular Dystrophy [DMD] amenable to exon 53 skipping....

Read the full article on Seeking Alpha

For further details see: